Our specialists

Mw. drs. Wendela Wessels

Pharmacist and founder of meamedicapro.com

She started her studies in Pharmacy without great expectations, but within 3 months the organic approach completely took hold of her. It turned out to be a fantastic study with a lot of depth. The graduation project, however, deviated somewhat from the hard substantive view by focusing on the perception of antidepressant users. The basis for mijnmedicijn.nl (which then led to meamedica.com) was then laid. After her first jobs, she noticed that the time of her co-caregivers was taken up by processes, but that the information the patient collects was often not listened to properly. In the same period her father fell ill, which after a few years led to his death. His skepticism - built up over the years - for the correctness of a diagnosis and subsequent treatments ensured a situation with minimal medical supervision. Being able to interpret or check a diagnosis freely and learning how to deal with it from the experiences of others was not yet possible.

mijnmedicijn.nl was the first step in that direction. After all, everyone builds up knowledge about their own condition and sensitivities. Not everyone will experience the same and the sharing of experiences developed into a valuable database of comparison material. That you can help someone else with your story in recognizing symptoms or causes is very powerful. This practical knowledge, combined with results from research, will be very valuable in the recognition of patterns and possibly also early detection of disorders.

Because large amounts of practical knowledge must be collected for this approach, internationalization was the starting point from the outset. As a result, the platform is now available in 12 countries, in 7 different languages. The goal was and still is to support the patient in his personal medical choices. The possibilities that the platform offers visitors are still expanding: it started with sharing experiences with medicines and conditions. A module has also been developed for dentists that provides insight into which conditions and medication have effects in the head and neck area. And the last addition is the ability to determine for yourself what effect DNA plays in the occurrence of side effects. But it certainly doesn’t end here...

Gerald Wright

President & CEO, global executive with leadership experience across multiple industries and continents.

Gerald Wright is an accomplished senior executive with global leadership experience across North and South America and Europe. He has led major organizations in sectors ranging from technology to industrial services, holding executive roles in Argentina, Germany, the U.S., and Canada. As President and CEO of his Silicon Valley-based consulting firm, Gerald advises companies on strategy, transformation, and growth. He previously held leadership roles at Siemens and Hewlett-Packard, where he drove large-scale initiatives in finance, governance, M&A, and operational efficiency. Gerald has served on numerous boards, including as Audit Committee Chair, for public, private, and non-profit organizations in the U.S. and Canada. He holds the ICD.D designation from the Institute of Corporate Directors and has taught at Stanford University’s Advanced Project Management Program. He is fluent in English, Spanish, and German.

Prof. dr. Frederik R. Rozema

Dental surgeon, professor of Oral Medicine Academic Center for Dentistry Amsterdam (ACTA) and Amsterdam UMC, University of Amsterdam, head of the department of Oral Medicine

He has been working at ACTA/Amsterdam UMC since 2012, where he supervises researchers on the relatively new topic of ‘Medical dental interactions’, focusing on the relationship between oral health and general health and vice versa. The field of research combines pre-eminently multidisciplinary knowledge. He is also a co-trainer and works as a dental surgeon.

W.M.H. (Willem) Rademacher

Oral and Maxillofacial surgeon in training at the Amsterdam University Medical Center

Willem Rademacher is an Oral and Maxillofacial surgeon in training at the Oral and Maxillofacial Surgery department of the Amsterdam University Medical Center (Amsterdam UMC), location AMC. He was a lecturer and PhD candidate in the Oral Medicine department (MTI) at ACTA. Here he provided master’s studies on the influences of medical co-morbidity and medicines on dental health and vice versa. The subject of his doctoral research concerns the safety of drug use and the consequences of these drugs for dental health and treatment. In that context, he stood at the cradle of the Medical Dental Interaction scanner.

Clin. Asst. Prof. Mag. Dr. Robert Terkola, aHPh

Clinical Assistant Professor, Oncology Pharmacist, Specialist in Hospital Pharmacy (aHPh), Consultant for Clinical Pharmacy and Pharmaceutical Innovation

Robert Terkola was born in Vienna, grew up in Himberg, and currently lives in Mödling in the Thermenregion of Lower Austria. He studied pharmacy at the University of Vienna and obtained his Mag. Pharm. degree in 1990. Eight years later he earned his doctorate (Dr. rer. nat.) in pharmaceutical chemistry with research on compatibility studies of infusion mixtures to prevent chemotherapy-induced nausea and vomiting. After qualifying as a public pharmacist, he moved directly into hospital pharmacy. At the Rudolfstiftung Hospital in Vienna he established one of the first oncology pharmacy services in Austria and implemented the world’s first installation of the gravimetric CATO® compounding system.

In 2002 he became head of the hospital pharmacy at Kaiser-Franz-Josef Hospital, where he introduced GDP logistics, unit-dose automation, robot-assisted GMP preparation of cytostatics, and an in-house analytical laboratory. From 2016 to 2019 he digitally modernized the Landesklinikum Wiener Neustadt by implementing CATO® and introducing new interfaces for laboratory, pathology, coding, and billing. At the same time, he worked as an oncology pharmacist and quality officer for the private PremiQaMed healthcare network. Since 1992 Robert has participated in more than 300 oncology phase I–III clinical studies. This extensive experience strengthened his conviction that real-world data must complement protocol data in order to bring innovations to patients faster and more cost-effectively. In 2005 he completed the European Health Leadership Programme (INSEAD), and in 2016 he founded the consulting firm Health-Concepts. In 2024 he implemented Austria’s first 3D medication printing service at the Marien Pharmacy in Vienna.

His qualifications include the Austrian diploma in hospital pharmacy (aHPh, 2004), qualification as a Qualified Person (2017), European Oncology Pharmacist (2020), pharmacogenomics (University of Florida, 2021), Comprehensive Medication Management (ACCP, 2021), and Certified Data Protection Officer (TÜV Austria, 2022). Since 2013 he has been Clinical Assistant Professor at the College of Pharmacy of the University of Florida. Since 2023 he has taught applied clinical pharmacology, pharmaceutical care, laboratory diagnostics, and evidence-based medicine at the Paracelsus Medical Private University in Salzburg, where he was named “Teacher of the Year” in 2025. He has given numerous international lectures, published more than forty scientific articles, and contributed to several books. Since 2001 he has been president of the Austrian Association for Oncology Pharmacy and since 2022 vice-president (research) of ESOP. In 2024 he became editor-in-chief of the European Journal of Oncology Pharmacy. Since 2017 he has been pursuing a PhD at the University of Groningen on the contribution of real-world data to the efficiency and affordability of cancer care.